COVID-19 & Telehealth Implementation: Stories from the Field
Click here to view the recording with the integrated audio transcript using the password below. external icon
The fully captioned video and edited transcript will be posted within the next few days.
This COCA Call will be held on Friday, March 27, 2020
During this COCA Call, presenters will discuss telehealth benefits and challenges during and after the COVID-19 pandemic. Presenters will share their experiences implementing telehealth across diverse healthcare settings and address considerations for its future use.
Erica Tindall, MSN, MPH, APRN, AGNP-C, CIC
Public Health Analyst
Rasheda Prescott, MD
Clinical Instructor, Internal Medicine and Pediatrics
Physician Informaticist, NYU Langone Health
Kemi Alli, MD
Chief Executive Officer
Henry J. Austin Health Center
Febe Wallace, MD
Director of Primary Care
Cherokee Health Systems
Due to the high demand we anticipate for this COCA Call, we encourage participants to consider viewing on Facebook. To see the call live, please click on COCA’s Facebook Page.
When: Tuesday, August 4, 2020,
2:00 p.m. to 3:30 p.m. (Eastern Time)
US: +1 669 254 5252
or +1 646 828 7666
International numbersexternal icon
US: +16692545252,,1608721092# or +16468287666,,1608721092#
Webinar ID: 160 872 1092Add to Calendar
Advanced registration is not required.
Date: Tuesday, August 4, 2020
Time: 2:00–3:30 P.M. ET
A few minutes before the webinar begins, please click the link below to join:
Webinar ID:160 872 1092
Or iPhone one-tap:
US: +16692545252,,1608721092# or +16468287666,,1608721092#
Dial-in (for higher quality, dial a number based on your current location):
US: +1 669 254 5252 or +1 646 828 7666
International numbers available at: https://www.zoomgov.com/u/ab0RjNhhPexternal icon
- Describe CDC’s telehealth guidance
- Discuss frontline clinician experiences related to telehealth implementation across the spectrum of health services and diverse patient bases
- Discuss how current experiences can inform strategies to identify and improve telehealth access and equity
- List strategies to facilitate and promote telehealth and address barriers to implementation during COVID-19 and beyond
COCA Call Objectives
- Cite background information on the topic covered during the presentation.
- Discuss CDC’s role in the topic covered during the presentation.
- Describe the topic’s implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.
None at this time.
To receive continuing education (CE) for WC2922-080420 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – COVID-19 & Telehealth Implementation: Stories from the Field, Tuesday, August 4, 2020, please visit TCEO and follow these 9 Simple Steps by Monday, September 7, 2020.
In order to receive continuing education (CE) for WD2922-080420 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – COVID-19 & Telehealth Implementation: Stories from the Field, Tuesday, August 4, 2020, (Web on Demand), please visit TCEO and follow these 9 Simple Steps by Thursday, September 8, 2022.
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-20-041-L04-P and enduring JA4008229-0000-20-042-H04-P course category.
This activity has been designated as Knowledge-Based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.
AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.
Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept commercial support for this continuing education activity.
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:email@example.com
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communication Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.